Asymmetric dimethylarginine (ADMA) modulates endothelial function -: therapeutic implications

被引：47

作者：

Böger, RH ^{[1
]}

机构：

[1] Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pharmacol, Clin Pharmacol Unit, D-20246 Hamburg, Germany

来源：

VASCULAR MEDICINE | 2003年 / 8卷 / 03期

关键词：

D O I：

10.1191/1358863x03vm501ed

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：149 / 151

页数：3

共 28 条

[1] Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus [J].

Abbasi, F ;

Asagmi, T ;

Cooke, JP ;

Lamendola, C ;

McLaughlin, T ;

Reaven, GM ;

Stuehlinger, M ;

Tsao, PS .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (10) :1201-+

[2] Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase [J].

Achan, V ;

Broadhead, M ;

Malaki, M ;

Whitley, G ;

Leiper, J ;

MacAllister, R ;

Vallance, P .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) :1455-1459

[3] Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].

Böger, RH ;

Bode-Böger, SM ;

Szuba, A ;

Tsao, PS ;

Chan, JR ;

Tangphao, O ;

Blaschke, TF ;

Cooke, JP .

CIRCULATION, 1998, 98 (18) :1842-1847

[4] An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes [J].

Böger, RH ;

Bode-Böger, SM ;

Tsao, PS ;

Lin, PS ;

Chan, JR ;

Cooke, JP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2287-2295

[5] When the endothelium cannot say 'NO' anymore -: ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease [J].

Böger, RH .

EUROPEAN HEART JOURNAL, 2003, 24 (21) :1901-1902

[6] LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases [J].

Böger, RH ;

Sydow, K ;

Borlak, J ;

Thum, T ;

Lenzen, H ;

Schubert, B ;

Tsikas, D ;

Bode-Böger, SM .

CIRCULATION RESEARCH, 2000, 87 (02) :99-105

[7] The L-arginine-nitric oxide pathway: Role in atherosclerosis and therapeutic implications [J].

Boger, RH ;

BodeBoger, SM ;

Frolich, JC .

ATHEROSCLEROSIS, 1996, 127 (01) :1-11

[8] The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor [J].

Böger, RH .

CARDIOVASCULAR RESEARCH, 2003, 59 (04) :824-833

[9] A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention [J].

Fathi, R ;

Haluska, B ;

Short, L ;

Marwick, TH .

AMERICAN JOURNAL OF MEDICINE, 2003, 114 (06) :445-453

[10]

Fickling SA, 1993, ENDOTHELIUM, V1, P137

← 1 2 3 →